Tregs protect against GVHD through the secretion of regulatory cytokines, including interleukin (IL)-10, IL-35 and transforming growth factor beta [35,36], and through the overexpression of immune checkpoint inhibitors such as PD-1 [37]. This evidence concerns the gene PDCD1 and graft versus host disease.